David Baynes, CEO of Fusion IP, talks about commercialising intellectual properties Simcyp made about £1.2 million profit last year, i2L Research is making some profit, Magnomatics cog-less gearboxes, Phase Focus’ very high level magnification lense-less microscopes, sustained drug release, and a drug delivery technology that will be fast to market.
Click here for the audio interview
Proactiveinvestors is a leading multi-media news organisation, investor portal and events management business with offices in New York, Sydney, Toronto, Frankfurt and London.
No comments:
Post a Comment